Same-day discharge after AF ablation procedure is becoming the preferred trend. Vascular closure devices have shortened the postprocedural bedrest, associated with increased patient satisfaction. Although this approach comes with a cost, it might benefit also the healthcare system.

Significant changes or cancellation of MCIT could result in limiting access to breakthrough medical technologies that could improve the health and well-being of Medicare beneficiaries. For these reasons, we encourage federal agencies to work together and CMS to implement the MCIT rule without delay to ensure timely access to breakthrough technologies